Do Adults with Mycoplasma pneumoniae Exhibit the Same Symptoms as Children?
Adults and children with Mycoplasma pneumoniae infection share similar core respiratory symptoms—primarily fever and cough—but differ significantly in fever intensity, disease severity, laboratory markers, and recovery patterns.
Core Symptom Similarities
Both age groups present with predominantly respiratory symptoms, with cough being the dominant manifestation in both populations 1. The classic "atypical pneumonia" presentation described in guidelines—slowly progressing illness with malaise, sore throat, low-grade fever, and cough developing over 3-5 days—applies to both adults and children 2. However, guidelines explicitly note that "in contrast to adults with pneumonia," certain features differ 2.
Key Differences Between Adults and Children
Fever Patterns
Children consistently demonstrate higher peak temperatures than adults:
This represents a clinically meaningful difference that can help distinguish presentations.
Disease Severity
Children experience more severe disease manifestations 3, 4:
- 18.2% of children develop severe Mycoplasma pneumoniae pneumonia (SMPP)
- All adults in family cluster studies had mild disease 3
- Children with SMPP show more extrapulmonary symptoms and multilobar infiltrates 4
Laboratory Markers
Distinct patterns emerge between age groups 1, 3, 4:
Children show:
- Elevated lactate dehydrogenase (LDH): 77.8% vs 11.3% in adults (p<0.001)
- Higher lymphocyte percentages
- Lower C-reactive protein (CRP) relative to disease severity
Adults show:
- Higher CRP levels
- Higher erythrocyte sedimentation rate (ESR)
- Elevated CRP alone predicts severity (AUC: 0.749) 1
Radiographic Patterns
Children typically present with:
- Bronchopneumonia (most common pattern)
- Bilateral lung involvement
- Multilobar infiltrates in severe cases 3, 4
Adults typically present with:
- Unilateral involvement
- Less extensive infiltrates 3
Recovery and Clinical Course
Adults recover significantly faster with a higher cumulative improvement rate from day 2 (HR: 1.916,95% CI: 1.267-2.899) 1. Children experience longer fever duration: 5.6±2.2 days versus 4.1±2.2 days in adults (p=0.002) 3.
Co-infection Risk
Children face substantially higher co-infection rates: 65.5% versus 22.8% in adults (p<0.001) 3. This complicates clinical presentation and may contribute to more severe disease in pediatric populations.
Clinical Pitfalls and Caveats
Important considerations:
- Clinical features alone cannot reliably establish M. pneumoniae as the etiologic diagnosis in either age group—the distinction between "typical" and "atypical" pneumonia has limited clinical value 5
- Elderly adults (≥60 years) present with lower fever magnitude and higher rates of comorbid illness, making diagnosis more challenging 6
- The diagnostic sensitivity using standard CAP scoring systems is significantly lower in elderly patients (50% vs 90%, p<0.0001) 6
- Co-infections are common and may mask or modify typical presentations 3
Age-Specific Predictors of Severity
For children, use the combination of:
- Elevated CRP
- Reduced lymphocyte percentage
- Pre-existing diseases (AUC: 0.744) 1
For adults, elevated CRP alone serves as the sole independent predictor of severity (AUC: 0.749) 1.
Treatment Response Differences
While macrolides remain first-line for children, quinolones show favorable recovery outcomes in adults 1. This age-based treatment differentiation reflects both pharmacologic considerations and the different severity profiles between populations.